PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue.
Saved in:
| Title: | PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue. |
|---|---|
| Authors: | Lee S; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Yoon SJ; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lim J; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Oh JH; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Ryu JS; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Kim G; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea., Kang H; HITS Inc., Seoul, Republic of Korea., Jo N; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lee S; HITS Inc., Seoul, Republic of Korea., Jang S; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lee Y; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea., Park Y; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Hwang ES; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Mar 12; Vol. 17, pp. 1755268. Date of Electronic Publication: 2026 Mar 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1755268 |
